Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Bayes Theorem »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Basilar Artery < Bayes Theorem < Behavior, Animal  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000357 (2019) Emma L. Simpson [Royaume-Uni] ; Shijie Ren [Royaume-Uni] ; Emma S. Hock [Royaume-Uni] ; John W. Stevens [Royaume-Uni] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Rachel Archer [Royaume-Uni] ; Suzy Paisley [Royaume-Uni] ; Matthew D. Stevenson [Royaume-Uni] ; Chloé Herpin [France] ; Salah Ghabri [France]Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.
000679 (2018) Erin Murray ; Alexandra Ellis ; Yekaterina Butylkova ; Martha Skup [États-Unis] ; Jasmina Kalabic [Allemagne] ; Vishvas Garg [États-Unis]Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis.
000880 (2018) Sang-Cheol Bae [Corée du Sud] ; Young Ho Lee [Corée du Sud]Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
000906 (2018) Peter A. Nigrovic [États-Unis] ; Timothy Beukelman [États-Unis] ; George Tomlinson [Canada] ; Brian M. Feldman [Canada] ; Laura E. Schanberg [États-Unis] ; Yukiko Kimura [États-Unis]Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
000C11 (2017) Jasvinder A. Singh ; Alomgir Hossain ; Elizabeth Tanjong Ghogomu ; Amy S. Mudano [États-Unis] ; Lara J. Maxwell ; Rachelle Buchbinder ; Maria Angeles Lopez-Olivo ; Maria E. Suarez-Almazor ; Peter Tugwell ; George A. WellsBiologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.
000C12 (2017) Jasvinder A. Singh ; Alomgir Hossain ; Amy S. Mudano [États-Unis] ; Elizabeth Tanjong Ghogomu ; Maria E. Suarez-Almazor ; Rachelle Buchbinder ; Lara J. Maxwell ; Peter Tugwell ; George A. WellsBiologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
000E99 (2016) Young Ho Lee [Corée du Sud] ; Sang-Cheol Bae [Corée du Sud]Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials.
001393 (2014) Jeroen P. Jansen ; Felicity Buckley [États-Unis] ; Fred Dejonckheere ; Sarika OgaleComparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.
001394 (2014) Hye-Lin Kim [Corée du Sud] ; Min-Young Lee ; Sun-Young Park ; Sun-Kyeong Park ; Ji-Hye Byun ; Sunhong Kwon ; Eui-Kyung LeeComparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach.
001816 (2011) Valentin Brodszky [Hongrie][Effectiveness of biological treatments based on ACR70 response in rheumatoid arthritis: indirect comparison and meta-regression using Bayes-model].
001926 (2011) Robert Launois [France] ; Bernard Avouac ; Francis Berenbaum ; Olivier Blin ; Isabelle Bru ; Bruno Fautrel ; Jean-Michel Joubert ; Jean Sibilia ; Bernard CombeComparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian metaanalysis.
001D04 (????) Eric Druyts [Canada] ; Jacqueline B. Palmer [États-Unis] ; Chakrapani Balijepalli [Canada] ; Keith Chan [Canada] ; Mir Sohail Fazeli [Canada] ; Vivian Herrera [États-Unis] ; Jeroen P. Jansen [Canada] ; Jay J H. Park [Canada] ; Steve Kanters [Canada] ; Andreas Reimold [États-Unis]Treatment modifying factors of biologics for psoriatic arthritis: a systematic review and Bayesian meta-regression.
001D07 (????) Sun-Kyeong Park [Corée du Sud] ; Min-Young Lee [Corée du Sud] ; Eun-Jin Jang [Corée du Sud] ; Hye-Lin Kim [Corée du Sud] ; Dong-Mun Ha [Corée du Sud] ; Eui-Kyung Lee [Corée du Sud]A comparison of discontinuation rates of tofacitinib and biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis: a systematic review and Bayesian network meta-analysis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Bayes Theorem" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Bayes Theorem" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Bayes Theorem
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021